Search results

Advice for people with MS - updated on 21 March

Researchers are addressing the gaps in information about the impact of COVID-19 on people with MS in Latin America.

Researchers in Israel have published the results of a small study exploring how well the Pfizer-BioNtech COVID-19 vaccine protects people with MS taking cladribine, fingolimod or ocrelizumab.

What does research tell us about how DMTs affect the body’s immune response to COVID-19 vaccines?

A look back at what the global MS movement has achieved during the pandemic.

Updated global advice for people with MS and the data behind it

Several healthcare companies answer MSIF's call to help MS organisations through pandemic

Start collecting COVID-19 and MS data

Register now: a webinar for people with MS and MS organisations – your questions answered on the COVID-19 & MS global data sharing initiative

MSIF grants over £500,000 to MS organisations to help them through the pandemic.

A message from the CEO of the MS International Federation as the global MS community faces the challenges of the coronavirus

When we come together, we can find answers, quickly, to global MS challenges.

The COVID-19 and MS global data sharing initiative is working to provide crucial information on the impact of the coronavirus on people with MS.

Sharing data to find answers quicker during COVID-19

Discover mental health resources from MS organisations across the globe on World Mental Health Day.

Six months into the COVID-19 Response Initiative

Esclerosis Múltiple Uruguay (EMUR) share their recent work and reflect on the positives at this time of great challenge.

The COVID-19 pandemic has brought unprecedented challenges to MS organisations across the world, and the Associação Brasileira de Esclerose Múltipla (ABEM) in Brazil is no exception.

Discover how MS organisations collaborate to translate vital MS information.

MS Australia celebrates national Women's Health Week

Could a vaccine treat MS?

The latest news from MS organisations in the Arab region

The MS International Federation is committed to protecting the privacy of the users of its website

Watch the International Progressive MS Alliance webcast here

Professor Robert Fox and Professor Ruth Ann Marrie named as incoming Chair and Vice Chair

Taking a moment to recognise multilingualism and resource-sharing across the MS movement on World Arabic Language Day

‘I don't count how many times I fall. I count how many times I stand up.’

We are seeking an experienced consultant to contribute to the evaluation and analysis of MSIF’s regional strategies and programmes in Latin America.

Step into the lab and meet Dr María José Ulloa Navas, a talented MS researcher from Ecuador. María José spoke with MSIF about her career so far, what drives her, and how she helps people affected by MS in her home country of Ecuador.

Explore resources from across the globe on exercise, nutrition and wellness for people affected by MS.

Digital fundraising learnings from MS organisations in Latin America

With over 500 million people across the world who speak Spanish there is an obvious need for access to MS information in Spanish.

MS affects people all over the world. MS registries are one of the many advances in MS research that are bringing us closer as a global MS community and closer to ending MS.

Contribute to the development and implementation of MSIF’s regional strategies and programmes

‘I actually want to be in a more corporate kind of role in which you would be married to your job a bit more. That excites me.’

'I keep worrying: What if I was unable to get my treatment for a month or so? What will be the consequences?'

Deadline for MSIF's Grants and Fellowhips is 30 June 2023

MSIF Du Pré Grants enable multiple sclerosis researchers and clinicians to undertake short placements in established MS research centres and clinics

MSIF's McDonald Fellowships fund 2-year research placements, in the memory of Professor Ian McDonald